Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease
Abstract
OBJECTIVE: Growing evidence suggests that vascular risk factors (VRF) contribute to cognitive decline. The aim of this study was to investigate the impact of VRF on the conversion from mild cognitive impairment (MCI) to Alzheimer disease (AD) dementia. METHODS: A total of 837 subjects with MCI were enrolled at baseline and followed up annually for 5 years. The incidence of AD dementia was investigated. A mixed random effects regression model was used to analyze the association between VRF and the progression of MCI assessed with Mini-Mental State Examination and instrumental Activities of Daily Living. Cox proportional hazard models were used to identify the association between VRF and dementia conversion, and to examine whether treatment of VRF can prevent dementia conversion. RESULTS: At the end of the follow-up, 298 subjects converted to AD dementia, while 352 remained MCI. Subjects with VRF had a faster progression in cognition and function relative to subjects without. VRF including hypertension, diabetes, cerebrovascular diseases, and hypercholesterolemia increased the risk of dementia conversion. Those subjects with MCI in whom all VRF were treated had a lower risk of dementia than those who had some VRF treated. Treatment of individual VRF including hypertension, diabetes, and hypercholesterolemia was associated with the reduced risk of AD conversion. CONCLUSION: VRF increased the risk of incident AD dementia. Treatment of VRF was associated with a reduced risk of incident AD dementia. Although our findings are observational, they suggest active intervention for VRF might reduce progression in MCI to AD dementia.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the MCI phase, interventional therapy could have the greatest potential to improve cognitive performance and slow disease progression.
“MCI represents an interesting field of research, because MCI increases the risk of later developing dementia, and, in this phase, an interventional therapy could have the greatest potential to improve cognitive performance and to slow down disease progression.3”
MCI increases the risk of later developing dementia.
“MCI represents an interesting field of research, because MCI increases the risk of later developing dementia, and, in this phase, an interventional therapy could have the greatest potential to improve cognitive performance and to slow down disease progression.3”
Evidence is mounting that managing high blood pressure and other conventional cardiovascular risk factors could favorably affect the clinical course of MCI.
“Indeed, evidence is mounting that the management of high blood pressure and other conventional cardiovascular risk factors could favorably affect the clinical course of MCI.3,32”
The citation lists haven’t been fetched yet
References 39 · Cited by 367
- Authors
- Li, J., Wang, Y. J., Zhang, M., Xu, Z. Q., Gao, C. Y., Fang, C. Q., Yan, J. C., & Zhou, H. D.
- Affiliations
- Army Medical University (CN)
- Venue
- Neurology
- Published
- 2011-04-26
- Volume
- 76
- Issue
- 17
- Pages
- 1485-1491
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2051064550
- Cited by
- 367
- References
- 39
- Citations by year
- 2026: 13 · 2025: 12 · 2024: 13 · 2023: 15 · 2022: 23 · 2021: 19 · 2020: 25 · 2019: 23 · 2018: 20 · 2017: 32 · 2016: 20 · 2015: 45 · 2014: 35 · 2013: 29 · 2012: 35
- FWCI
- 23.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Keywords
- vascular risk factors, mild cognitive impairment, Alzheimer's disease, conversion to dementia, hypertension, diabetes mellitus, cerebrovascular disease, hypercholesterolemia, cognitive decline, dementia prevention
- MeSH terms
- Aged, Alzheimer Disease, Cerebrovascular Disorders, Cognition Disorders, Female, Humans, Longitudinal Studies, Male, Mental Status Schedule, Middle Aged, Neuropsychological Tests, Peptides, Regression Analysis, Residence Characteristics, Retrospective Studies, Risk Factors, Incidence, Disease Progression, Statistics, Nonparametric, Intercellular Signaling Peptides and Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review